Welcome to LookChem.com Sign In|Join Free
  • or
(S)-4-(tert-butoxycarbonyl)-1-(3-chlorophenyl)-5-[2-(methanesulfonyl)ethyl]piperazin-2-one is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

183500-40-5

Post Buying Request

183500-40-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

183500-40-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 183500-40-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,8,3,5,0 and 0 respectively; the second part has 2 digits, 4 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 183500-40:
(8*1)+(7*8)+(6*3)+(5*5)+(4*0)+(3*0)+(2*4)+(1*0)=115
115 % 10 = 5
So 183500-40-5 is a valid CAS Registry Number.

183500-40-5Relevant academic research and scientific papers

Method of treating cancer

-

Page/Page column 94, (2010/02/12)

The present invention relates to methods of treating cancer using a combination of a compound which is an antineoplastic agent and a compound which is a inhibitor of prenyl-protein transferase, which methods comprise administering to said mammal, either s

Method of treating cancer

-

, (2008/06/13)

The present invention relates to methods of treating cancer using a combination of a compound which is a PSA conjugate and a compound which is a inhibitor of prenyl-protein transferase, which methods comprise administering to said mammal, either sequentially in any order or simultaneously, amounts of at least two therapeutic agents selected from a group consisting of a compound which is a PSA conjugate and a compound which is a inhibitor of prenyl-protein transferase. The invention also relates to methods of preparing such compositions.

INHIBITORS OF FARNESYL-PROTEIN TRANSFERASE

-

, (2008/06/13)

The present invention is directed to compounds which inhibit farnesyl-protein transferase (FTase) and the farnesylation of the oncogene protein Ras. The invention is further directed to chemotherapeutic compositions containing the compounds of this invention and methods for inhibiting farnesyl-protein transferase and the farnesylation of the oncogene protein Ras

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 183500-40-5